Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer

Gastric Cancer

Volumn 12, Issue SUPPL. 1, 2009, Pages 10-15

  Sasako, Mitsuru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Adjuvant treatment; Chemoradiotherapy; Fluorouracil; Gastric cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN C; TS 1; UFT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANOREXIA; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; HUMAN; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH CANCER;

EID: 64949144527     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-008-0465-8     Document Type: Review

References (21)

1. K. Oba S. Morita A. Tsuburaya Y. Kodera M. Kobayashi J. Sakamoto 2006 Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a metaanalysis of centrally randomized controlled clinical trials in Japan J Chemother 18 311 317
2. J.S. Macdonald S.R. Smalley J. Benedetti S.A. Hundahl N.C. Estes G.N. Stemmermann 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730
3. D. Cunningham W.H. Allum S.P. Stenning J.N. Thompson C.J.H. van de Velde M. Nicolson 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
4. B. Neri F. Andreoli B. Boffi D. Francesconi R. Mazzanti F. Medi 2001 Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow up Br J Cancer 84 878 880
5. B. Neri V. de Leonardis S. Romano F. Andreoli L.M. Pernice L. Bruno 1996 Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study Br J Cancer 73 549 552
6. E. Bajetta R. Buzzoni L. Mariani E. Beretta F. Bozzetti G. Bordogna 2002 Adjuvant chemotherapy in gastric cancer: 5-year results of a randomized study by the Italian Trials in Medical Oncology (ITMO) Group Ann Oncol 13 299 307
7. J. Chipponi M. Hugier D. Pezet N. Basso J.M. Hay P. Quandalle 2004 Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer Am J Surg 187 440 445
8. O. Bouché M. Ychou P. Burtin L. Bedenne M. Ducreux M. Lebreton 2005 Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer; 7-year results of the FFCD randomized phase III trial (8801) Ann Oncol 16 1488 1497
9. D. Nitti J. Wils J.G. Dos Santos G. Fountzilas P.F. Conte C. Sava 2006 Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG Ann Oncol 17 262 269
10. F. De Vita F. Giuliani M. Orditura G. Galizia N. Di Martino F. Montemurro 2007 Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase IIItrial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) Ann Oncol 18 1354 1358
11. T. Nakajima A. Nashimoto M. Kitamura T. Kito T. Iwanaga K. Okabayashi 1999 Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial Lancet 354 273 277
12. A. Nashimoto T. Nakajima H. Furukawa M. Kitamura T. Kinoshita Y. Yamamura 2003 Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer; Japan Clinical Oncology Group 9206-1 J Clin Oncol 21 2282 2287
13. Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, Nakajima T, et al. No survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer: randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer. Presented at the 2005 Gastrointestinal Cancers Symposium; 2005 January 27-29; Hollywood, FL, USA. Alexandria, VA, American Society of Clinical Oncology; 2005.
14. T. Nakajima T. Kinoshita A. Nashimoto M. Sairenji T. Yamaguchi J. Sakamoto 2007 Randomized controlled study of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer Br J Surg 94 1468 1476
15. S. Sakuramoto M. Sasako T. Yamaguchi T. Kinoshita M. Fujii A. Nashimoto 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820
16. P.G. McCulloch A. Ochiai G.M. O'Dowd J.R. Nash M. Sasako S. Hirohashi 1995 Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan Cancer 75 920 925
17. J.J. Bonenkamp C.J. van de Velde G.H. Kampschöer J. Hermans P. Hermanek M. Bemelmans 1993 Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients World J Surg 17 410 415
18. A.M.G. Bunt J. Hermans V.T. Smit C.J. van de Velde G.J. Fleuren J.A. Bruijn 1995 Surgical/pathological stage migration confounds comparisons of gastric cancer survival rates between Japan and western countries J Clin Oncol 13 19 25
19. Macdonald JS, Smalley S, Benedetti J, Estes N, Haller D, Ajani JA, et al. Presented at the 2004 Gastrointestinal Cancers Symposium; 2004 Jan 22-24; San Francisco, CA, USA. Alexandria, VA, American Society of Clinical Oncology; 2004.
20. S.A. Hundahl J.S. Macdonald J.B. Benedetti T. Fitzsimmons 2002 Surgical treatment variation in a prospective randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment Ann Surg Oncol 9 278 286
21. S.K. Kim D.H. Lim J.Y. Lee W.K. Kang J.S. Macdonald C.H. Park 2005 An observational study suggesting clinical benefit for adjuvant postoperative chemoradiotherapy in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 63 1279 1285